(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-10-(((propoxy-d7)methoxy)imino)oxacyclotetradecan-2-one
Roxithromycin Impurity 13-d7 is a fully characterized chemical compound used as a reference standard of API Roxithromycin. The standard offered is compliant with regulatory guidelines. Roxithromycin Impurity 13-d7 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
Roxithromycin Impurity 5 (1-(2-Methoxyethoxy) Methanol)
M.F.
M.W. 106.063
CAT# AR-R11637
CAS# 67796-27-4
